Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
麻豆原创 Analysis and Insights: Global Peptide Synthesis Service 麻豆原创
The global Peptide Synthesis Service market is projected to grow from US$ 1078 million in 2024 to US$ 1663.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
The customized peptide synthesis market is driven by the growing demand for peptides in various fields, including pharmaceuticals, biotechnology, and research. Customized peptides are essential tools for drug development, therapeutic applications, and biochemical research. The increasing focus on personalized medicine and targeted therapies further propels market growth. Moreover, advancements in peptide synthesis technologies and the availability of automated synthesis platforms have improved the efficiency and scalability of customized peptide production. However, challenges include the complexity of synthesizing certain peptides, the need for stringent quality control measures, and the cost associated with custom synthesis services. Addressing these challenges through continuous research and development, process optimization, and competitive pricing will be crucial for sustaining the growth of the customized peptide synthesis market.
Report Covers:
This report presents an overview of global market for Peptide Synthesis Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Peptide Synthesis Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Peptide Synthesis Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Peptide Synthesis Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Peptide Synthesis Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Peptide Synthesis Service revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Bachem
PolyPeptide
GL Biochem
Xinbang
Hybio
USVPeptides
Thermofischer
ScinoPharm
Genscript
AnaSpec
New England Peptide
CPC Scientific
JPT
21st Century Bio
LifeTein
Proimmune
Biomatik
Segment by Type
CRO Peptides
CMO Peptides
Generic API Peptides
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Peptide Synthesis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Synthesis Service companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide Synthesis Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Peptide Synthesis Service 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 CRO Peptides
1.2.3 CMO Peptides
1.2.4 Generic API Peptides
1.3 麻豆原创 by Application
1.3.1 Global Peptide Synthesis Service 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Synthesis Service 麻豆原创 Perspective (2019-2030)
2.2 Global Peptide Synthesis Service Growth Trends by Region
2.2.1 Peptide Synthesis Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peptide Synthesis Service Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Peptide Synthesis Service Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Peptide Synthesis Service 麻豆原创 Dynamics
2.3.1 Peptide Synthesis Service Industry Trends
2.3.2 Peptide Synthesis Service 麻豆原创 Drivers
2.3.3 Peptide Synthesis Service 麻豆原创 Challenges
2.3.4 Peptide Synthesis Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Peptide Synthesis Service by Players
3.1.1 Global Peptide Synthesis Service Revenue by Players (2019-2024)
3.1.2 Global Peptide Synthesis Service Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Peptide Synthesis Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Peptide Synthesis Service, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Peptide Synthesis Service 麻豆原创 Concentration Ratio
3.4.1 Global Peptide Synthesis Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Synthesis Service Revenue in 2023
3.5 Global Key Players of Peptide Synthesis Service Head office and Area Served
3.6 Global Key Players of Peptide Synthesis Service, Product and Application
3.7 Global Key Players of Peptide Synthesis Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Synthesis Service Breakdown Data by Type
4.1 Global Peptide Synthesis Service Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Peptide Synthesis Service Forecasted 麻豆原创 Size by Type (2025-2030)
5 Peptide Synthesis Service Breakdown Data by Application
5.1 Global Peptide Synthesis Service Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Peptide Synthesis Service Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Peptide Synthesis Service 麻豆原创 Size (2019-2030)
6.2 North America Peptide Synthesis Service 麻豆原创 Size by Type
6.2.1 North America Peptide Synthesis Service 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Peptide Synthesis Service 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Peptide Synthesis Service 麻豆原创 Share by Type (2019-2030)
6.3 North America Peptide Synthesis Service 麻豆原创 Size by Application
6.3.1 North America Peptide Synthesis Service 麻豆原创 Size by Application (2019-2024)
6.3.2 North America Peptide Synthesis Service 麻豆原创 Size by Application (2025-2030)
6.3.3 North America Peptide Synthesis Service 麻豆原创 Share by Application (2019-2030)
6.4 North America Peptide Synthesis Service 麻豆原创 Size by Country
6.4.1 North America Peptide Synthesis Service 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Peptide Synthesis Service 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Peptide Synthesis Service 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Peptide Synthesis Service 麻豆原创 Size (2019-2030)
7.2 Europe Peptide Synthesis Service 麻豆原创 Size by Type
7.2.1 Europe Peptide Synthesis Service 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Peptide Synthesis Service 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Peptide Synthesis Service 麻豆原创 Share by Type (2019-2030)
7.3 Europe Peptide Synthesis Service 麻豆原创 Size by Application
7.3.1 Europe Peptide Synthesis Service 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe Peptide Synthesis Service 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe Peptide Synthesis Service 麻豆原创 Share by Application (2019-2030)
7.4 Europe Peptide Synthesis Service 麻豆原创 Size by Country
7.4.1 Europe Peptide Synthesis Service 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Peptide Synthesis Service 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Peptide Synthesis Service 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Peptide Synthesis Service 麻豆原创 Size (2019-2030)
8.2 China Peptide Synthesis Service 麻豆原创 Size by Type
8.2.1 China Peptide Synthesis Service 麻豆原创 Size by Type (2019-2024)
8.2.2 China Peptide Synthesis Service 麻豆原创 Size by Type (2025-2030)
8.2.3 China Peptide Synthesis Service 麻豆原创 Share by Type (2019-2030)
8.3 China Peptide Synthesis Service 麻豆原创 Size by Application
8.3.1 China Peptide Synthesis Service 麻豆原创 Size by Application (2019-2024)
8.3.2 China Peptide Synthesis Service 麻豆原创 Size by Application (2025-2030)
8.3.3 China Peptide Synthesis Service 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Peptide Synthesis Service 麻豆原创 Size (2019-2030)
9.2 Asia Peptide Synthesis Service 麻豆原创 Size by Type
9.2.1 Asia Peptide Synthesis Service 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Peptide Synthesis Service 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Peptide Synthesis Service 麻豆原创 Share by Type (2019-2030)
9.3 Asia Peptide Synthesis Service 麻豆原创 Size by Application
9.3.1 Asia Peptide Synthesis Service 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia Peptide Synthesis Service 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia Peptide Synthesis Service 麻豆原创 Share by Application (2019-2030)
9.4 Asia Peptide Synthesis Service 麻豆原创 Size by Region
9.4.1 Asia Peptide Synthesis Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Peptide Synthesis Service 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Peptide Synthesis Service 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Peptide Synthesis Service 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide Synthesis Service Introduction
11.1.4 Bachem Revenue in Peptide Synthesis Service Business (2019-2024)
11.1.5 Bachem Recent Developments
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Peptide Synthesis Service Introduction
11.2.4 PolyPeptide Revenue in Peptide Synthesis Service Business (2019-2024)
11.2.5 PolyPeptide Recent Developments
11.3 GL Biochem
11.3.1 GL Biochem Company Details
11.3.2 GL Biochem Business Overview
11.3.3 GL Biochem Peptide Synthesis Service Introduction
11.3.4 GL Biochem Revenue in Peptide Synthesis Service Business (2019-2024)
11.3.5 GL Biochem Recent Developments
11.4 Xinbang
11.4.1 Xinbang Company Details
11.4.2 Xinbang Business Overview
11.4.3 Xinbang Peptide Synthesis Service Introduction
11.4.4 Xinbang Revenue in Peptide Synthesis Service Business (2019-2024)
11.4.5 Xinbang Recent Developments
11.5 Hybio
11.5.1 Hybio Company Details
11.5.2 Hybio Business Overview
11.5.3 Hybio Peptide Synthesis Service Introduction
11.5.4 Hybio Revenue in Peptide Synthesis Service Business (2019-2024)
11.5.5 Hybio Recent Developments
11.6 USVPeptides
11.6.1 USVPeptides Company Details
11.6.2 USVPeptides Business Overview
11.6.3 USVPeptides Peptide Synthesis Service Introduction
11.6.4 USVPeptides Revenue in Peptide Synthesis Service Business (2019-2024)
11.6.5 USVPeptides Recent Developments
11.7 Thermofischer
11.7.1 Thermofischer Company Details
11.7.2 Thermofischer Business Overview
11.7.3 Thermofischer Peptide Synthesis Service Introduction
11.7.4 Thermofischer Revenue in Peptide Synthesis Service Business (2019-2024)
11.7.5 Thermofischer Recent Developments
11.8 ScinoPharm
11.8.1 ScinoPharm Company Details
11.8.2 ScinoPharm Business Overview
11.8.3 ScinoPharm Peptide Synthesis Service Introduction
11.8.4 ScinoPharm Revenue in Peptide Synthesis Service Business (2019-2024)
11.8.5 ScinoPharm Recent Developments
11.9 Genscript
11.9.1 Genscript Company Details
11.9.2 Genscript Business Overview
11.9.3 Genscript Peptide Synthesis Service Introduction
11.9.4 Genscript Revenue in Peptide Synthesis Service Business (2019-2024)
11.9.5 Genscript Recent Developments
11.10 AnaSpec
11.10.1 AnaSpec Company Details
11.10.2 AnaSpec Business Overview
11.10.3 AnaSpec Peptide Synthesis Service Introduction
11.10.4 AnaSpec Revenue in Peptide Synthesis Service Business (2019-2024)
11.10.5 AnaSpec Recent Developments
11.11 New England Peptide
11.11.1 New England Peptide Company Details
11.11.2 New England Peptide Business Overview
11.11.3 New England Peptide Peptide Synthesis Service Introduction
11.11.4 New England Peptide Revenue in Peptide Synthesis Service Business (2019-2024)
11.11.5 New England Peptide Recent Developments
11.12 CPC Scientific
11.12.1 CPC Scientific Company Details
11.12.2 CPC Scientific Business Overview
11.12.3 CPC Scientific Peptide Synthesis Service Introduction
11.12.4 CPC Scientific Revenue in Peptide Synthesis Service Business (2019-2024)
11.12.5 CPC Scientific Recent Developments
11.13 JPT
11.13.1 JPT Company Details
11.13.2 JPT Business Overview
11.13.3 JPT Peptide Synthesis Service Introduction
11.13.4 JPT Revenue in Peptide Synthesis Service Business (2019-2024)
11.13.5 JPT Recent Developments
11.14 21st Century Bio
11.14.1 21st Century Bio Company Details
11.14.2 21st Century Bio Business Overview
11.14.3 21st Century Bio Peptide Synthesis Service Introduction
11.14.4 21st Century Bio Revenue in Peptide Synthesis Service Business (2019-2024)
11.14.5 21st Century Bio Recent Developments
11.15 LifeTein
11.15.1 LifeTein Company Details
11.15.2 LifeTein Business Overview
11.15.3 LifeTein Peptide Synthesis Service Introduction
11.15.4 LifeTein Revenue in Peptide Synthesis Service Business (2019-2024)
11.15.5 LifeTein Recent Developments
11.16 Proimmune
11.16.1 Proimmune Company Details
11.16.2 Proimmune Business Overview
11.16.3 Proimmune Peptide Synthesis Service Introduction
11.16.4 Proimmune Revenue in Peptide Synthesis Service Business (2019-2024)
11.16.5 Proimmune Recent Developments
11.17 Biomatik
11.17.1 Biomatik Company Details
11.17.2 Biomatik Business Overview
11.17.3 Biomatik Peptide Synthesis Service Introduction
11.17.4 Biomatik Revenue in Peptide Synthesis Service Business (2019-2024)
11.17.5 Biomatik Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bachem
PolyPeptide
GL Biochem
Xinbang
Hybio
USVPeptides
Thermofischer
ScinoPharm
Genscript
AnaSpec
New England Peptide
CPC Scientific
JPT
21st Century Bio
LifeTein
Proimmune
Biomatik
听
听
*If Applicable.
